Healthcare News and Research

Latest Healthcare News and Research

Large urban health systems do worse on government patient satisfaction scores

The largest urban health systems, which serve as safety nets for large patient populations with lower socioeconomic status and greater likelihood to speak English as a second language, do worse on government patient satisfaction scores than smaller, non-urban hospitals likely to serve white customers with higher education levels, according to a new study by Mount Sinai researchers published this month in the Journal of Hospital Medicine.

20 May 2015

Teens with slower cognitive processing speed experience depression, anxiety symptoms as adults

Teens with slower performance on a test of "cognitive processing speed" are more likely to have depression and anxiety symptoms as adults, reports a paper in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.

20 May 2015

Monash University researcher helps identify right type of Ebola vaccine trial

An Australian researcher has helped identify the kind of human trial that is most effective for testing Ebola vaccines.

20 May 2015

Corus CAD test can help clinicians rule-out low-risk patients from additional cardiac testing

CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a multi-center, community-based patient registry, the PRESET Registry, evaluating the use of the Corus CAD test in patients with symptoms suggestive of obstructive coronary artery disease (CAD) in the primary care setting.

20 May 2015

Study shows trophon EPR effective in inactivating high-risk, cancer-causing HPV

A new study presented at the Society for Healthcare Epidemiology of America has demonstrated that the trophon EPR is the only high level disinfection system proven to kill natural, infectious, high-risk human papilloma virus (HPV) under normal use conditions.

20 May 2015

Study shows trophon EPR effective in inactivating high-risk, cancer-causing HPV

20 May 2015

Total costs of treatment for babies with neonatal abstinence syndrome on the rise

As more infants are born to mothers with dependence on prescription pain medications, the costs of treatment for babies with neonatal abstinence syndrome (NAS) have increased dramatically, suggests a report in the March/April issue of the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine.

20 May 2015

No added benefit with pazopanib over ranibizumab for neovascular AMD

Pazopanib eye drops do not enhance visual outcomes in patients with neovascular age-related macular degeneration beyond those achieved with ranibizumab alone, study findings indicate.

19 May 2015

Promising preliminary results for AKB-9778 in diabetic macular oedema

AKB-9778, a small molecule competitive inhibitor of vascular endothelial-protein tyrosine phosphatase, has a good safety and efficacy profile in patients with diabetic macular oedema, suggests a preliminary dose-escalation study.

19 May 2015

Similar diabetic macular oedema outcomes with deferred vs prompt laser therapy

Visual acuity outcomes are comparable in diabetic macular oedema patients who receive laser treatment 24 weeks or more after initiation of ranibizumab injections and those for whom laser therapy is initiated concurrently, show the 5-year results of a US study.

19 May 2015

Risk factors predict geographic atrophy after anti-VEGF treatment of RAP

Researchers have found three factors that could identify which patients with retinal angiomatous proliferation receiving anti-vascular endothelial growth factor treatment are likely to develop geographic atrophy.

19 May 2015

hESC-derived cells offer source of macular tissue repair and replacement

Subretinal transplantation of retinal pigment epithelium derived from human embryonic stem cells appears to be a well-tolerated means of treating age-related macular degeneration and Stargardt’s macular dystrophy, suggest two open-label phase I/II studies.

19 May 2015

DWHP announces sale of Health & Safety Institute to Riverside

DW Healthcare Partners, a healthcare-focused private equity, announced the sale of its portfolio company, Health & Safety Institute, Inc., to The Riverside Company, a New York-based private equity firm. The terms of the transaction were not disclosed.

19 May 2015

MedVantx launches MedStart Formulary Connect program for health systems and ACOs

MedVantx, Inc., a leading provider of point-of-care medication access, adherence and direct-to-patient consumer engagement programs, today announced the Company's MedStart Formulary Connect program. This innovative program equips leading health systems and ACOs with new formulary management tools that are designed to build greater alignment and advance the traditional medication formulary program upstream in the value chain to the point of care.

19 May 2015

CLDF collaborates with Walgreens to offer free rapid HCV testing

The Chronic Liver Disease Foundation announced today that it's collaborating with Walgreens to offer free hepatitis C (HCV) testing with the OraQuick HCV Rapid Test at more than 60 Walgreens retail pharmacies in 12 major cities throughout the country.

19 May 2015

California PACE enrollment continues to rise

Enrollment in the California Program for All-Inclusive Care for the Elderly (PACE) nearly doubled during the last four-and-a-half years based on the latest numbers reported from 11 programs operating 30 PACE centers in the state.

19 May 2015

OrthoSpace announces completion of financing transaction

OrthoSpace Ltd. announced today the completion of a financing transaction led by HealthpointCapital, LLC, which also includes existing investors Smith & Nephew and TriVentures.

19 May 2015

ORIG3N, LabCorp form strategic partnership

ORIG3N, Inc., a pioneer in regenerative medicine and provider of induced pluripotent stem cell (iPSC) storage, called LifeCapsule, today announced a strategic collaboration with Laboratory Corporation of America Holdings.

19 May 2015

Stoltenberg, Qlik partner to help healthcare clients drive down costs, improve patient care

Stoltenberg Consulting, Inc., a premier healthcare information technology consulting firm, today announced its partnership with leading visual analytics vendor Qlik® to help healthcare clients best utilize their data to drive down costs and improve patient care.

19 May 2015

Naldemedine shows promise in treating OIC in patients with chronic non-cancer pain.

Shionogi Inc. today announced data from a Phase IIb study that showed 0.2 mg and 0.4 mg of naldemedine demonstrated statistically significant efficacy in treating opioid-induced constipation (OIC) in patients with chronic non-cancer pain.

19 May 2015